Inari Medical Inc.

USDC – Southern District of New York

february 29, 2024

CLASS PERIOD: February 24, 2022 – february 28, 2024
LEAD PLAINTIFF DEADLINE: July 12, 2024

Join Investigation

Principle Contacts

Laurence D. King

LKing@kaplanfox.com

Inari Medical (NASDAQ: NARI): Kaplan Fox Investigates Potential Securities Fraud at Inari Medical

Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc.  (“Inari Medical” or the “Company”)(NASDAQ: NARI). Click Here to Join Investigation.

If you acquired Inari Medical shares and would like to discuss our investigation, please click here or contact us by emailing pmayer@kaplanfox.com or by calling (646) 315-9003.

On February 28, 2024, after the market close, Inari announced fourth quarter and full-year 2023 financial results and disclosed receipt of a civil investigative demand in December 2023 from the U.S. Department of Justice (“DOJ”) in connection with an investigation under the federal Anti-Kickback Statute and Civil False Claims Act over certain payments to healthcare professionals.  During the Company conference call, Chief Financial Officer Mitch Hill stated that the DOJ is “primarily requesting information related to meals and consulting service payments provided to healthcare professionals.”

Following this news, the price of Inari Medical shares fell by more than 21% in intraday trading on February 29, 2024.

WHY CONTACT KAPLAN FOX

Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey.  With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand.  Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients.  For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

If you have any questions about this investigation, please contact:

Pamela A. Mayer
KAPLAN FOX & KILSHEIMER LLP
800 Third Avenue, 38th Floor
New York, New York 10022
(646) 315-9003
E-mail: pmayer@kaplanfox.com

Laurence D. King
KAPLAN FOX & KILSHEIMER LLP
1999 Harrison Street, Suite 1560
Oakland, California 94612
(415) 772-4704
Fax:  (415) 772-4707
E-mail: lking@kaplanfox.com

Connect with Kaplan Fox.

Receive a complimentary case review now.